FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520455780> ?p ?o ?g. }

• W1520455780 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CATrabectedin (Yondelis, ET-743) is a marine-derived antitumor agent that is currently used for the treatment of sarcoma and, in combination with pegylated-liposomal doxorubicin, of platinum-sensitive ovarian cancer patients. After binding to the DNA minor groove, trabectedin induces a potent transcription inhibition on tumor cells and tumor-associated macrophages. The resolution of functional DNA adducts generated by the drug is known to occur through the coordinated action of multiple DNA repair pathways, including homologous recombination (HR), a process that gives rise to double-strand breaks (DSBs). Trabectedin treatment at nanomolar concentrations does indeed produce a high proportion of DSB-positive tumor cells with abundant γ-H2AX foci and an S-phase delay/arrest by activation of the DNA replication checkpoints. We had previously shown the synergism (CI < 1) of the combination of Trabectedin with Olaparib (AZD-2281) in the breast cancer cell lines HCC-1937, MCF-7, MDA-MB-231 and MDA-MB-436. In this work we have investigated the mechanism of this synergistic effect at the molecular level. While the treatment with either compound alone (0.05 nM Trabectedin or 5 μM Olaparib for 72 hours) induced only a mild antiproliferative effect, the combination of both compounds at the mentioned concentrations induced strong apoptosis in all the breast cancer cell lines. Exposure to 0.5 and 2.5 nM Trabectedin for 72 hours induced a clear accumulation of γ-H2AX foci. Exposure to Olaparib alone induced only a mild DNA damage at 72 hours with all the concentrations tested. Olaparib induced a clear inhibition of PARylation at concentrations from 1-2.5 μM of the compound. The combination of both drugs, keeping Olaparib at 5 μM and varying the concentrations of Trabectedin from 0.05 to 2.5 nM, demonstrated a synergistic effect on the accumulation of histone H2AX phosphorylation, as analyzed both by western blotting and immunofluorescence microscopy. When comparing all these results, it was clearly seen that, although Trabectedin or Olaparib generated a considerable amount of DSBs, the combination of both drugs induced a higher proportion of DNA damage that remained at very high levels even after 72 hours of treatment. Thus, the observed synergistic effect seems to be the result of higher accumulation of DSBs after the administration of the combination of Trabectedin with Olaparib.Citation Format: Sonia Avila, Marta Martinez, Victoria Moneo, Juan F. Martinez-Leal, Carmen Cuevas, Luis F. Garcia-Fernandez, Carlos M. Galamarini. Synergistic combination of Trabectedin and Olaparib in breast cancer tumor cell lines. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1686. doi:10.1158/1538-7445.AM2014-1686" @default.
• W1520455780 created "2016-06-24" @default.
• W1520455780 creator A5014697391 @default.
• W1520455780 creator A5018241587 @default.
• W1520455780 creator A5033015070 @default.
• W1520455780 creator A5037738920 @default.
• W1520455780 creator A5060070120 @default.
• W1520455780 creator A5072192012 @default.
• W1520455780 creator A5087069519 @default.
• W1520455780 date "2014-09-30" @default.
• W1520455780 modified "2023-09-26" @default.
• W1520455780 title "Abstract 1686: Synergistic combination of Trabectedin and Olaparib in breast cancer tumor cell lines" @default.
• W1520455780 doi "https://doi.org/10.1158/1538-7445.am2014-1686" @default.
• W1520455780 hasPublicationYear "2014" @default.
• W1520455780 type Work @default.
• W1520455780 sameAs 1520455780 @default.
• W1520455780 citedByCount "0" @default.
• W1520455780 crossrefType "proceedings-article" @default.
• W1520455780 hasAuthorship W1520455780A5014697391 @default.
• W1520455780 hasAuthorship W1520455780A5018241587 @default.
• W1520455780 hasAuthorship W1520455780A5033015070 @default.
• W1520455780 hasAuthorship W1520455780A5037738920 @default.
• W1520455780 hasAuthorship W1520455780A5060070120 @default.
• W1520455780 hasAuthorship W1520455780A5072192012 @default.
• W1520455780 hasAuthorship W1520455780A5087069519 @default.
• W1520455780 hasConcept C121608353 @default.
• W1520455780 hasConcept C126322002 @default.
• W1520455780 hasConcept C142724271 @default.
• W1520455780 hasConcept C143425029 @default.
• W1520455780 hasConcept C182979987 @default.
• W1520455780 hasConcept C185592680 @default.
• W1520455780 hasConcept C2776694085 @default.
• W1520455780 hasConcept C2778256501 @default.
• W1520455780 hasConcept C2778629024 @default.
• W1520455780 hasConcept C2779962180 @default.
• W1520455780 hasConcept C2780427987 @default.
• W1520455780 hasConcept C2780752271 @default.
• W1520455780 hasConcept C2781303535 @default.
• W1520455780 hasConcept C502942594 @default.
• W1520455780 hasConcept C552990157 @default.
• W1520455780 hasConcept C55493867 @default.
• W1520455780 hasConcept C71924100 @default.
• W1520455780 hasConcept C82381507 @default.
• W1520455780 hasConcept C98274493 @default.
• W1520455780 hasConceptScore W1520455780C121608353 @default.
• W1520455780 hasConceptScore W1520455780C126322002 @default.
• W1520455780 hasConceptScore W1520455780C142724271 @default.
• W1520455780 hasConceptScore W1520455780C143425029 @default.
• W1520455780 hasConceptScore W1520455780C182979987 @default.
• W1520455780 hasConceptScore W1520455780C185592680 @default.
• W1520455780 hasConceptScore W1520455780C2776694085 @default.
• W1520455780 hasConceptScore W1520455780C2778256501 @default.
• W1520455780 hasConceptScore W1520455780C2778629024 @default.
• W1520455780 hasConceptScore W1520455780C2779962180 @default.
• W1520455780 hasConceptScore W1520455780C2780427987 @default.
• W1520455780 hasConceptScore W1520455780C2780752271 @default.
• W1520455780 hasConceptScore W1520455780C2781303535 @default.
• W1520455780 hasConceptScore W1520455780C502942594 @default.
• W1520455780 hasConceptScore W1520455780C552990157 @default.
• W1520455780 hasConceptScore W1520455780C55493867 @default.
• W1520455780 hasConceptScore W1520455780C71924100 @default.
• W1520455780 hasConceptScore W1520455780C82381507 @default.
• W1520455780 hasConceptScore W1520455780C98274493 @default.
• W1520455780 hasLocation W15204557801 @default.
• W1520455780 hasOpenAccess W1520455780 @default.
• W1520455780 hasPrimaryLocation W15204557801 @default.
• W1520455780 hasRelatedWork W1618306469 @default.
• W1520455780 hasRelatedWork W1964685410 @default.
• W1520455780 hasRelatedWork W2024795485 @default.
• W1520455780 hasRelatedWork W2027413502 @default.
• W1520455780 hasRelatedWork W2032386131 @default.
• W1520455780 hasRelatedWork W2043754647 @default.
• W1520455780 hasRelatedWork W2116219049 @default.
• W1520455780 hasRelatedWork W2497665393 @default.
• W1520455780 hasRelatedWork W2504216116 @default.
• W1520455780 hasRelatedWork W2605942164 @default.
• W1520455780 hasRelatedWork W2740155286 @default.
• W1520455780 hasRelatedWork W2741298166 @default.
• W1520455780 hasRelatedWork W2971801617 @default.
• W1520455780 hasRelatedWork W3003435698 @default.
• W1520455780 hasRelatedWork W3062447400 @default.
• W1520455780 hasRelatedWork W3130393297 @default.
• W1520455780 hasRelatedWork W3174403800 @default.
• W1520455780 hasRelatedWork W3181764517 @default.
• W1520455780 hasRelatedWork W3182150826 @default.
• W1520455780 hasRelatedWork W3205059998 @default.
• W1520455780 isParatext "false" @default.
• W1520455780 isRetracted "false" @default.
• W1520455780 magId "1520455780" @default.
• W1520455780 workType "article" @default.